The Rush Approach to Benign Blood Disorders Care
Whether you are seeking an initial diagnosis or a second opinion, you will find an answer at Rush. Our hematologists are experts at diagnosing and managing all types of noncancerous blood disorders.
Your treatment will depend on the blood disorder you have, which makes an accurate diagnosis vital. At Rush, our hemato-pathologists are specially trained to diagnose complex blood disorders, including rare conditions, using advanced laboratory approaches.
We care for hundreds of patients every year with various types of benign blood disorders, including the following:
- Anemias, or red blood cell disorders, including aplastic anemia, pernicious anemia, thalassemia and paroxysmal nocturnal hemoglobinuria (PNH)
- Bleeding disorders, such as hemophilia, von Willebrand Disease and idiopathic thrombocytopenic purpura (ITP)
- Blood clotting disorders, including thrombophilia and thrombotic thrombocytopenic purpura
- Platelet disorders, which include thrombocytopenia, and thrombocytosis
- White blood cell disorders, such as leukocytosis and leukopenia
At Rush, you'll have access to the following advanced treatments for benign blood disorders:
- Medications (e.g., growth factors, clotting factors, immunoglobin therapies)
- Nutritional counseling
- Blood transfusions
Meet our benign blood disorders care providers
Rush Excellence in Benign Blood Disorders Care
- Patient-centered chronic disease management: If you have a chronic blood disorder, you will see our team regularly. In addition to monitoring your blood counts, we will teach you how to prevent and manage symptoms and keep your condition under control — so you can pursue the life you desire.
- Access to clinical trials and research breakthroughs: Many of our hematologists are also researchers who are working to better understand the clinical underpinnings of blood disorders and identify new treatments. As a result, you will have access to new treatments and therapies before they are widely available elsewhere. You may also have the opportunity to participate in clinical trials aimed at improving outcomes for all patients with blood disorders.
- Comprehensive care for sickle cell anemia: As a leader in treating sickle cell anemia, Rush offers comprehensive care that includes the most advanced treatments for sickle cell anemia, including new treatments like crizanlizumab (Adakveo), voxeletor (oxbryta) and endari.The program is also dedicated to managing pain, urgent care and patient advocacy in Springfield to improve prevention and treatment efforts for sickle cell anemia.
- Second opinions: Rush welcomes patients seeking second opinions for benign blood disorders and rare coagulation disorders. This will help you confirm your diagnosis and allows you to explore all of your treatment options.
- Thrombotic microangiopathies research: Rush University Medical Center is the only hospital in Chicago that is a member of the U.S. Thrombotic Microangiopathies Consortium, which organizes research efforts for thrombotic microangiopathies.
